Literature DB >> 18925698

Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.

Valdi Pesutić-Pisac1, Ante Punda, Ivo Gluncić, Vladimir Bedeković, Anka Pranić-Kragić, Nenad Kunac.   

Abstract

AIM: To determine the prognostic value of cell cycle regulators cyclin D1 and p27 for papillary thyroid carcinomas.
METHODS: Analysis included 180 patients with papillary thyroid carcinoma who underwent surgery at Split University Hospital Center between 1999 and 2001. Clinical data were obtained from clinical charts and histopathology reports. Immunohistochemistry was performed on formalin-fixed, paraffin-embedded tissue by antibody p27 and cyclin D1. Quantification was based on the intensity and distribution of nuclear staining.
RESULTS: Univariate analysis showed that sex (P=0.019) and capsular invasion (P=0.010) were significant predictors of lymph node metastases, whereas age (P=0.96), histopathological variant (P=0.075), size (P=0.556) and multifocality (P=0.131) were not. Univariate analysis also showed that overexpression of cyclin D1 (P<0.001) and underexpression of p27 (P<0.001) predicted lymph node metastases in papillary thyroid carcinomas. There was a significant correlation between cyclin D1 (P=0.024) and p27 (P=0.029) expression in two prognostic groups of low and high risk. Low risk group was cyclin D1 negative and p27 positive, while high risk group was cyclin D1 positive and p27 negative. Multivariate analysis confirmed that sex (P=0.041), capsular invasion (P=0.027), and p27 (P<0.001) were strong independent predictors of lymph node metastases in the high-risk group.
CONCLUSIONS: Immunohistochemical analysis of p27 expression may be a valuable tool for identifying risk of lymph node metastases and more aggressive behavior of papillary thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18925698      PMCID: PMC2582357          DOI: 10.3325/cmj.2008.5.643

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  21 in total

1.  Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment.

Authors:  L E Sanders; B Cady
Journal:  Arch Surg       Date:  1998-04

2.  Reduced expression of the cell-cycle inhibitor p27Kip1 is associated with progression and lymph node metastasis of gastric carcinoma.

Authors:  D H Kim; H I Lee; E S Nam; H S Shin; J H Sohn; C H Park; D S Yoon; S Y Song; Y E Park
Journal:  Histopathology       Date:  2000-03       Impact factor: 5.087

3.  Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma.

Authors:  Mark L C Khoo; Nigel J P Beasley; Shereen Ezzat; Jeremy L Freeman; Sylvia L Asa
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

4.  Point mutations of ras oncogenes are an early event in thyroid tumorigenesis.

Authors:  H Namba; S A Rubin; J A Fagin
Journal:  Mol Endocrinol       Date:  1990-10

5.  Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer.

Authors:  M Sellers; S Beenken; A Blankenship; S J Soong; E Turbat-Herrera; M Urist; W Maddox
Journal:  Am J Surg       Date:  1992-12       Impact factor: 2.565

6.  Prognostic factors in differentiated carcinoma of the thyroid gland.

Authors:  J P Shah; T R Loree; D Dharker; E W Strong; C Begg; V Vlamis
Journal:  Am J Surg       Date:  1992-12       Impact factor: 2.565

7.  BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.

Authors:  Marina N Nikiforova; Edna T Kimura; Manoj Gandhi; Paul W Biddinger; Jeffrey A Knauf; Fulvio Basolo; Zhaowen Zhu; Riccardo Giannini; Giuliana Salvatore; Alfredo Fusco; Massimo Santoro; James A Fagin; Yuri E Nikiforov
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

8.  Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome.

Authors:  W M McConahey; I D Hay; L B Woolner; J A van Heerden; W F Taylor
Journal:  Mayo Clin Proc       Date:  1986-12       Impact factor: 7.616

9.  [Poorly differentiated carcinoma of the thyroid--immunohistochemical evaluation of p53 and p27 protein expression].

Authors:  W Wierzchowski; P Szybiński; W Nowak; K Nowak; Z Szybiński; M Buziak-Bereza; J Stachura
Journal:  Wiad Lek       Date:  2001

10.  Prognostic role of p27Kip1 and apoptosis in human breast cancer.

Authors:  J Wu; Z Z Shen; J S Lu; M Jiang; Q X Han; J A Fontana; S H Barsky; Z M Shao
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  15 in total

1.  Synchronous Papillary Carcinoma of Thyroid and Lung.

Authors:  Tao Wang; Ian Blumer; Scott Boerner; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2016-09       Impact factor: 3.943

2.  The Value of HBME-1 and Claudin-1 Expression Profile in the Distinction of BRAF-Like and RAS-Like Phenotypes in Papillary Thyroid Carcinoma.

Authors:  Hasan Gucer; Pelin Bagci; Recep Bedir; Ibrahim Sehitoglu; Ozgur Mete
Journal:  Endocr Pathol       Date:  2016-09       Impact factor: 3.943

Review 3.  Prognostic biomarkers in thyroid cancer.

Authors:  Paula Soares; Ricardo Celestino; Miguel Melo; Elsa Fonseca; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

Review 4.  Circulating microRNAs and Clinicopathological Findings of Papillary Thyroid Cancer: A Systematic Review.

Authors:  Georgios Geropoulos; Kyriakos Psarras; Maria Papaioannou; Dimitrios Giannis; Maria Meitanidou; Konstantinos Kapriniotis; Nikolaos Symeonidis; Efstathios T Pavlidis; Theodoros E Pavlidis; Konstantinos Sapalidis; Nada Mabrouk Ahmed; Tarek Ezzat Abdel-Aziz; Mohammad M R Eddama
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

5.  Cell Cycle Protein Expression in Neuroendocrine Tumors: Association of CDK4/CDK6, CCND1, and Phosphorylated Retinoblastoma Protein With Proliferative Index.

Authors:  Yan Shi; Zhi Rong Qian; Sui Zhang; Wanwan Li; Yohei Masugi; Tingting Li; Jennifer A Chan; Juhong Yang; Annacarolina Da Silva; Mancang Gu; Li Liu; Tsuyoshi Hamada; Keisuke Kosumi; Trevor Dutton; Lauren K Brais; Reiko Nishihara; Charles S Fuchs; Shuji Ogino; Matthew H Kulke
Journal:  Pancreas       Date:  2017 Nov/Dec       Impact factor: 3.327

6.  Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma.

Authors:  Andrii Dinets; Mykola Hulchiy; Anastasios Sofiadis; Mehran Ghaderi; Anders Höög; Catharina Larsson; Jan Zedenius
Journal:  Eur J Endocrinol       Date:  2012-03-28       Impact factor: 6.664

7.  Molecular pathways associated with aggressiveness of papillary thyroid cancer.

Authors:  Salvatore Benvenga; Christian A Koch
Journal:  Curr Genomics       Date:  2014-06       Impact factor: 2.236

8.  Understanding molecular markers in recurrent oral squamous cell carcinoma treated with chemoradiation.

Authors:  Seema Gupta; Vandana Singh Kushwaha; Sandeep Verma; Huma Khan; M L B Bhatt; Nuzhat Husain; Mahendra Pal Singh Negi; Vivek Vidyadhar Bhosale; Ashim Ghatak
Journal:  Heliyon       Date:  2016-12-05

9.  Correlation between expressions of Cyclin-D1, EGFR and p53 with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.

Authors:  Huma Khan; Seema Gupta; Nuzhat Husain; Sanjeev Misra; Negi Mps; Naseem Jamal; Ashim Ghatak
Journal:  BBA Clin       Date:  2014-11-21

10.  ClC-3 Chloride Channel Proteins Regulate the Cell Cycle by Up-regulating cyclin D1-CDK4/6 through Suppressing p21/p27 Expression in Nasopharyngeal Carcinoma Cells.

Authors:  Dong Ye; Hai Luo; Zhouyi Lai; Lili Zou; Linyan Zhu; Jianwen Mao; Tim Jacob; Wencai Ye; Liwei Wang; Lixin Chen
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.